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1682-606X/Copyright ª 2015, TaiwanSummary A 56-year-old woman presented with epigastric pain and loss of appetite and
weight for the preceding 3 weeks. Clinically, she was jaundiced with upper quadrant abdom-
inal tenderness. Initial blood tests and imaging scans suggested cholangiocarcinoma. Intrao-
peratively, no malignancy was observed. A frozen section biopsy suggested tuberculosis
(TB). However, subsequent serological examination showed that the patient was nonreactive
for human immunodeficiency virus, hepatitis B, hepatitis C, and acid-fast bacilli. A chest radio-
graph also showed no evidence of pulmonary TB. The patient was then placed on antituber-
cular therapy and her condition improved. Primary hepatic TB was not initially considered
during diagnosis because of its low prevalence, but this led to performing an unnecessary sur-
gery on this patient. We review the literature on this rare condition and discuss potential stra-
tegies for diagnosing and managing patients with primary hepatic TB.
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Tuberculosis (TB), a re-emerging disease, is a cause of
growing worldwide concern because of its increased unusual
presentations. Primary hepatic tuberculoma is rare in
healthy immunocompetent patients. Most hepatic involve-
ment in TB is considered secondary because of its associationElsevier Taiwan LLC. All rights reserved.
Managing primary hepatic tuberculosis 95with miliary TB. The macronodular form of hepatic TB was
first reported in 1858 by Bristowe. Primary hepatic TB results
from tubercular bacilli gaining access to the portal vein
from a microscopic tubercular focus in the bowel with sub-
sequent healing occurring at the site of entry and leaving no
trace.1Figure 2 Fluoroscopic image of the biliary tree at endo-
scopic retrograde cholangiopancreatography. Note the nar-
rowing of the common hepatic duct at the confluence of the
intrahepatic ducts (annotated with the arrow) and the dilated
left and right intrahepatic ducts.2. Case Report
A 56-year-old woman presented with epigastric pain and
loss of weight and appetite for the preceding 3 weeks.
Clinically, she was jaundiced with right upper quadrant
tenderness. Initial blood investigations revealed anemia, a
deranged liver profile consistent with obstructive jaundice,
and elevated CA 19-9 level (562 U/mL). Carcinoembryonic
antigen (CEA) level was 2.7 ng/mL. Abdominal computed
tomography (CT) demonstrated an ill-defined heteroge-
neously enhancing mass of 3.5 cm  4.0 cm with periportal
lymphadenopathy at the hepatic hilum. Chol-
angiocarcinoma was diagnosed on the basis of the afore-
mentioned history and clinical findings. Endoscopic
retrograde cholangiopancreatography showed a hilar stric-
ture (Fig. 1). Following this, the patient underwent a biliary
decompression procedure. Later, she underwent a central
hepatectomy. Intraoperatively, yellowish nodules on both
liver lobes were observed with mesenteric and omental
lymphadenopathies, which were not visualized on CT
(Fig. 2). A frozen section biopsy showed predominantly
lymphoplasmacytic inflammatory infiltrates, multiple
granuloma with central necrosis, and multinucleated
Langhans-type giant cells suggestive of TB. In addition, a
complete histopathological examination confirmed the
aforementioned findings (Fig. 3). In subsequent testing, the
patient was nonreactive for human immunodeficiency virus,
hepatitis B, hepatitis C, and acid-fast bacilli. In addition,
thoracic CT scan showed no evidence of pulmonary TB. The
patient was placed on antitubercular therapy, and her
condition improved. A CT scan 6 months later demonstrated
that the size of the lesions was reduced when compared
with the size of lesions observed at presentation (Figs. 4
and 5).Figure 1 Multiple superficial lesions on both the liver lobes
(annotated with arrows). These lesions were not visualized on
the preoperative computed tomography scan.3. Discussion
Approximately one-third of the world’s population is
latently infected with Mycobacterium TB, with 2 million
deaths reported annually, predominantly in developing
countries.2 In addition, TB remains the leading cause of
death among AIDS patients.3 Levin classified hepatic TB as
miliary TB, pulmonary TB with hepatic involvement, pri-
mary hepatic TB, focal tuberculoma or abscess or tuber-
culous cholangitis.4 Approximately 80% of hepatic TB are of
the miliary form. Isolated primary hepatic TB is rare
because of the low oxygen tension within the liver, making
it unfavorable for mycobacterial growth.5
The difficulty in managing patients with primary hepatic
TB lies in arriving at correct diagnosis. Low prevalence of
primary hepatic TB means that it is not a leading cause in
the list of differential diagnosis. Its clinical presentation
and results of laboratory and radiological investigation are
also nonspecific. The classical presentation of fever, mal-
aise, weight loss, and jaundice may or may not be evident
in all cases. Therefore, a high degree of clinical suspicion is
required for diagnosis.
The presence of a deranged hepatic function, hypo-
albuminemia, anemia, and hyponatremia are not specific to
TB. The sensitivity of serology for acid-fast staining bacilli
and blood cultures is as low as 0e45% and 10e60%,
respectively. Tuberculin skin test is typically positive and
when used in combination with polymerase chain reaction,
which has a sensitivity and specificity of 58% and 96%,
respectively, improves detection rates.6 However, these
specific tests can be requested only if there is clinical
suspicion.
Radiological investigations are nonspecific and may
mimic various other benign or malignant conditions.7
Numerous other diseases show lesions of a variable den-
sity with a peripheral enhancement on abdominal CT scans.
Areas of focal calcification and liquefactive necrosis,
Figure 3 Histological slides of the hepatic tissue under low (10) and high (20) magnification (hematoxylin and eosin stained).
These slides demonstrate mixed inflammatory infiltrates of predominantly lymphoplasmacytic cells accompanied by periductal
fibrosis. Multiple granulomas with central necrosis and multinucleated Langhans-type giant cells were observed. Lymphocytes and a
rim of fibroblasts also surrounded these granulomas. No features of malignancy were observed.
Figure 4 Axial slice, portovenous phase of the patient’s
computed tomography scan at presentation. Note the ill-
defined hypodense lesion (arrow) in the region of the conflu-
ence of the hepatic duct. The features were suggestive of a
hilar cholangiocarcinoma as they exhibited a slight enhance-
ment with contrast. Note the dilated left and right intrahepatic
ducts.
Figure 5 Axial slice, portovenous phase of the patient’s
computed tomography scan 6 months after antitubercular
therapy. Note that the hilar lesion (arrow) is now smaller in
size. The intrahepatic ducts are also less dilated.
96 I. Ghoneim et al.indicating simultaneously existing different pathological
stages, are observed on CT scans in hepatic TB.8 However,
they are also observed in liver abscesses.
Therefore, tissue histology is the most reliable method
for correct diagnosis. The samples for tissue histology are
most effectively obtained with laparoscopic-assisted liver
biopsy for reducing the risk of parietal tumor seeding whena lesion is in fact a malignancy. Other features suggesting
malignancy may also be explored during the procedure. A
frozen section of a hepatic lesion can help health care
providers decide the appropriate next step in the man-
agement of the disease. Although percutaneous biopsy is a
viable option, seeding along the needle track is a small but
serious concern. A poor yield of representative tissue is
another disadvantage. Diaz et al6 reported that, using
guided percutaneous needle biopsy, only 2 of 21 cases of
local hepatic TB were correctly diagnosed.
Managing primary hepatic tuberculosis 97Our patient neither had previous exposure to TB nor
presented with the classical signs of the disease. The
investigation results were not specific to a diagnosis of TB.
This was confounded by the elevated CA 19-9 level. This
misdirection probably sidetracked us from considering TB
as a possible differential.
Diagnosing a tubercular lesion of the liver preoperatively
remains challenging. Although rare, it should be given
greater consideration in the differential diagnosis of he-
patic lesions. Thus far, a diagnostic laparoscopy is still
considered an effective diagnostic tool in uncertain cases.
This procedure, although invasive, allows for a more thor-
ough assessment of suspicious hepatic lesions. Confirmation
with frozen section biopsy, intraoperative ultrasound, and
subsequent liver resection can also be performed in the
same clinical setting, if deemed necessary. This can effec-
tively reduce unnecessary work-up and delay in treatment.
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